Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$70.96 - $82.35 $127,727 - $148,230
-1,800 Reduced 94.74%
100 $7,000
Q2 2024

Aug 14, 2024

SELL
$62.12 - $84.15 $12,424 - $16,830
-200 Reduced 9.52%
1,900 $136,000
Q1 2024

May 15, 2024

SELL
$65.98 - $77.09 $13,196 - $15,418
-200 Reduced 8.7%
2,100 $147,000
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $121,509 - $179,906
2,300 New
2,300 $177,000
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $29,504 - $34,392
-400 Reduced 26.67%
1,100 $89,000
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $107,430 - $129,930
1,500 New
1,500 $111,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.